Stock Pick

  • Oxford BioMedica inks deal to make AstraZeneca’s potential COVID-19 vaccine

    Oxford BioMedica inks deal to make AstraZeneca's potential COVID-19 vaccine

    from Yahoo Finance https://ift.tt/2X89X3h

  • Hedge Funds Have Never Been This Bullish On The Sherwin-Williams (SHW)

    Hedge Funds Have Never Been This Bullish On The Sherwin-Williams (SHW)Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]

    from Yahoo Finance https://ift.tt/2M1KPF5

  • Novartis inks deal to make Mass General Brigham’s COVID-19 vaccine candidate

    Novartis inks deal to make Mass General Brigham's COVID-19 vaccine candidateNovartis’s gene therapy unit AveXis has signed a manufacturing deal to help produce a novel genetic COVID-19 vaccine candidate being developed by U.S. researchers in Massachusetts, a spokeswoman for the Swiss drugmaker confirmed on Thursday. Massachusetts General Hospital and Massachusetts Eye and Ear are developing a vaccine candidate that relies on adeno-associated viral (AAV) vector technology to produce immunity. AveXis, which makes Novartis’s $2.1 million-per-patient gene therapy Zolgensma for the hereditary disease spinal muscular atrophy, is contributing technology, expertise and its manufacturing supply chain at no cost, it said.

    from Yahoo Finance https://ift.tt/3c9myYb

The Latest